ATARA BIOTHERAPEUTICS, INC. Operating Lease Right-of-Use Assets
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Operating Lease Right-of-Use Assets of $6.69 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-12
- 2026-06-30: Operating Lease, Right-of-Use Asset $6.69M.
- 2026-03-31: Operating Lease, Right-of-Use Asset $6.88M.
- 2025-12-31: Operating Lease, Right-of-Use Asset $7.06M.
- 2025-09-30: Operating Lease, Right-of-Use Asset $10.71M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2026-06-30 | $6.69M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $6.88M 10-Q · filed 2026-05-12 |
| 2025-12-31 | $7.06M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $10.71M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $11.03M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $31.73M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $39.81M 10-K · filed 2026-03-16 |
| 2024-09-30 | $45.83M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $48.95M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $51.98M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $54.94M 10-K · filed 2025-03-07 |
| 2023-09-30 | $59.17M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $62.20M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $65.14M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $68.02M 10-K · filed 2024-03-28 |
| 2022-09-30 | $70.83M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $73.58M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $18.93M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $26.16M 10-K · filed 2023-02-08 |
| 2021-09-30 | $25.07M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $11.55M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $11.93M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $12.30M 10-K · filed 2022-02-28 |
| 2020-09-30 | $12.07M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $13.32M 10-Q · filed 2020-08-05 |
| 2020-03-31 | $13.69M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $14.01M 10-K · filed 2021-03-01 |
| 2019-09-30 | $14.20M 10-Q · filed 2019-11-07 |
| 2019-06-30 | $14.40M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $14.04M 10-Q · filed 2019-05-09 |
| 2019-01-01 | $14.30M 10-K · filed 2021-03-01 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |